NeoGenomics Inc (NEO): Cash & Equivalents
$159.62M
As of 2025-12-31
$145.54M
As of 2026-06-30
-15.4%
3-year compound annual growth
-6.9%
5-year compound annual growth
+21.2%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $159.62M | -56.5% | 2026-02-17, Balance as of period end |
| 2024-12-31 | $367.01M | +7.2% | 2026-02-17, Balance as of period end |
| 2023-12-31 | $342.49M | +30.1% | 2025-02-18, Balance as of period end |
| 2022-12-31 | $263.18M | -16.9% | 2024-02-20, Balance as of period end |
| 2021-12-31 | $316.83M | +38.5% | 2023-02-24, Balance as of period end |
| 2020-12-31 | $228.71M | +32.2% | 2023-02-24, Balance as of period end |
| 2019-12-31 | $173.02M | n/m | 2022-02-25, Balance as of period end |
| 2018-12-31 | $9.81M | -23.5% | 2021-02-25, Balance as of period end |
| 2017-12-31 | $12.82M | +2.4% | 2019-02-26, Balance as of period end |
| 2016-12-31 | $12.53M | -46.5% | 2019-02-26, Balance as of period end |
| 2015-12-31 | $23.42M | -30.5% | 2018-03-13, Balance as of period end |
| 2014-12-31 | $33.69M | +596.9% | 2017-03-14, Balance as of period end |
| 2013-12-31 | $4.83M | +158.8% | 2016-04-18, Balance as of period end |
| 2012-12-31 | $1.87M | -28.9% | 2015-03-03, Balance as of period end |
| 2011-12-31 | $2.63M | +139.6% | 2014-02-24, Balance as of period end |
| 2010-12-31 | $1.10M | n/a | 2012-03-12, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| NeoGenomics Inc (NEO) | 2025-12-31 | $159.62M | -56.5% |
| UL Solutions Inc. (ULS) | 2025-12-31 | $295.00M | -1.0% |
| 20/20 Biolabs, Inc. (AIDX) | 2025-12-31 | $1.03M | -42.5% |
Compare NEO, ULS, AIDX side by side · Screen every company in Services-Testing Laboratories ↗